Evidence map›Paper›PMID 33123209›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Antioxidant Effect of Standardized Extract of Propolis (EPP-AF®) in Healthy Volunteers: A "Before and After" Clinical Study.

Débora P Diniz, Daniela Aparecida Lorencini, Andresa Aparecida Berretta, Monica A C T Cintra, Erica N Lia, Alceu A Jordão, Eduardo B Coelho

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. An Advanced Combinatorial System fromPharmaceuticals (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Editorial: Therapeutic potential of propolis-fromFrontiers in pharmacology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Débora P DinizDepartment of Internal Medicine, Ribeirão Preto Medical School, Ribeirão Preto, Brazil.
Daniela Aparecida LorenciniDepartment of Internal Medicine, Ribeirão Preto Medical School, Ribeirão Preto, Brazil.
Andresa Aparecida BerrettaLaboratory of Research, Development and Innovation, Apis Flora Indl. Coml. Ltda., Ribeirão Preto, São Paulo, Brazil.
Monica A C T CintraGeneral Clinical Research Center, Teaching Hospital Ribeirão Preto, Ribeirão Preto, Brazil.
Erica N LiaDepartment of Dentistry, Faculty of Health Sciences, University of Brasília, Brasilia, Brazil.
Alceu A JordãoDepartment of Health Sciences, University of São Paulo, Ribeirão Preto, Brazil.
Eduardo B CoelhoDepartment of Internal Medicine, Ribeirão Preto Medical School, Ribeirão Preto, Brazil.ORCID https://orcid.org/0000-0003-3491-3396

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPropolis is rich in polyphenols, especially flavonoids and phenolic acids, and has significant antioxidant activity, shown mainly in "

objectiveThe aim of this study was to evaluate the antioxidant efficacy and safety of a standardized propolis extract in healthy volunteers.

designA two-phase sequential, open-label, nonrandomized, before and after clinical trial.

methodsHealthy participants received two EPP-AF® doses (375 and 750 mg/d, P.O, tid) during 7 ± 2 days, starting with the lower doses. Immediately before starting EPP-AF® administration and at the end of each 7-day dosing schedule, blood and urine samples were collected for quantification of 8-OHDG (8-hydroxydeoxyguanosine) and 8-ISO (8-isoprostanes) in urine and GSH (reduced glutathione), GSSG (oxidized glutathione), SOD (superoxide dismutase), FRAP (Ferric Reducing Antioxidant Power), vitamin E, and MDA (malondialdehyde) in plasma.

resultsIn our study, we had 34 healthy participants (67.7% women, 30 ± 8 years old, 97% white). The 8-ISO, a biomarker of lipid peroxidation, decreased with both doses of EPP-AF® compared to baseline (8-ISO, 1.1 (0.9-1.3) versus 0.85 (0.75-0.95) and 0.89 (0.74-1.0), ng/mg creatinine,

conclusionEPP-AF® reduced biomarkers of oxidative stress cell damage in healthy humans, with increased antioxidant enzymatic capacity, especially of SOD. This trial is registered with the Brazilian Registry of Clinical Trials (ReBEC, RBR-9zmfs9).

Identifiers

PMID33123209
PMCPMC7585652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.